The prevalence of hepatitis B virus infection in the United States in the era of vaccination.
about
Combination Therapy for Chronic Hepatitis B: Current IndicationsHepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention StrategiesSLE: Another Autoimmune Disorder Influenced by Microbes and Diet?Hepatitis B Management in the Pregnant Patient: An UpdateHepatitis B among Asian Americans: Prevalence, progress, and prospects for controlCharacterization of Acute and Chronic Hepatitis B Virus Genotypes in CanadaHepatocellular Carcinoma Risk in Alaska Native Children and Young Adults with Hepatitis B Virus: Retrospective Cohort AnalysisInfections in Cancer Patients with Solid Tumors: A Review.Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease.Use of the International Classification of Diseases, 9th revision, coding in identifying chronic hepatitis B virus infection in health system data: implications for national surveillance.Progress in vaccination towards hepatitis B control and elimination in the Region of the AmericasA population-based study examining hepatitis B virus infection and immunization rates in Northwest ChinaLower than expected hepatitis B virus infection prevalence among first generation Koreans in the U.S.: results of HBV screening in the Southern California Inland Empire.Prevalence of metabolic syndrome and risks of abnormal serum alanine aminotransferase in Hispanics: a population-based study.The increasing burden of imported chronic hepatitis B--United States, 1974-2008.Chronic liver disease in the Hispanic population of the United States.Hepatitis B screening practice among older Chinese in the Greater Washington, DC, area.Is universal HBV vaccination of healthcare workers a relevant strategy in developing endemic countries? The case of a university hospital in NigerDifferences in somatic mutation landscape of hepatocellular carcinoma in Asian American and European American populations.Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infectionPrevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007Antiviral treatment among pregnant women with chronic hepatitis B.Risk factors associated with hepatitis B exposure and the reliability of five rapid kits commonly used for screening blood donors in Ghana.Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center.Interleukin-16 gene polymorphisms are considerable host genetic factors for patients' susceptibility to chronic hepatitis B infection.Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program.Changing trends in viral hepatitis-associated hospitalizations in the American Indian/Alaska Native population, 1995-2007Impact of hepatitis B and C infection on health services utilization in homeless adults: a test of the Gelberg-Andersen Behavioral Model for Vulnerable Populations.Utilization of hepatitis B core antibody-positive donor liver graftsHepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B.Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.Persistence of immunity in healthy adults aged ≥ 50 years primed with a hepatitis B vaccine 3 years previously.Defining an integrative approach for health promotion and disease prevention: a population health equity framework.Hepatitis B in Ghana: a systematic review & meta-analysis of prevalence studies (1995-2015)Low rates of hepatitis B virus screening at the onset of chemotherapy.4'-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus.Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010.Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities.The Cancer-Associated Virus Landscape in HIV Patients with Oral Hairy Leukoplakia, Kaposi's Sarcoma, and Non-Hodgkin Lymphoma.Ten-Year Changes in the Hepatitis B Prevalence in the Birth Cohorts in Korea: Results From Nationally Representative Cross-Sectional Surveys
P2860
Q24604492-732FF8DA-9CAD-4CDB-A06D-7BAD49D9FBC6Q26746486-C7F3DA7F-B7AF-4D8F-98FC-774F4046F52BQ26773130-7DE9498A-EBF4-4242-BF27-778909AACAB5Q28066219-81A98F69-D3A2-4BB1-943F-1F70BB5A3165Q28088546-2E952442-6FCB-4A4E-8045-940B4702AEDBQ28548476-BCCFB352-22A0-40A9-8AF0-C533BA3A9800Q30151678-9CE067D6-5B90-4AE5-8C84-288D32C6FC41Q30238576-C0FA69E5-CB4E-4802-AC9E-8CB793E632BEQ30244568-C6223DF0-0663-4013-B4EB-8C20DB19CB75Q30596772-910A8BB8-69BD-4A84-A9EC-7F353C8BB551Q33568248-D7EB00DF-186D-4C30-8335-91CCD3D6DAC4Q33618408-B821E7CA-4A71-41DA-A9A2-9C5A6550D0BFQ33678323-5DD1FFE7-06B9-4800-A2D1-04799647D4BDQ33947985-1F83193D-5829-4328-B4A3-FD249AE715F8Q34098106-86DFF8CF-4F0A-4888-9D1E-468B7E83AB39Q34284875-34BED797-3F9E-4E7F-B911-2D24944C3F8DQ34383363-4120B544-A130-4CAA-A764-DD2C44F23099Q34412410-65BD7B14-FA1B-4B46-AE0F-5AD62D506878Q34529055-BE22C2D9-8086-40AE-9043-DB84C73B9D46Q34670561-1D759AF7-D133-45C1-A8EC-D19854A9816DQ34675189-6171FA8E-E490-4F06-9D67-12A298679A84Q34762578-C5BD270B-4FDA-48CA-BE05-55EDCD95823FQ34969698-9D218A16-8DDD-488B-8230-3BD6BCD1C254Q35037621-92C8CA08-73B7-4DB2-82B7-068FB61C596BQ35066814-0BA1F6CC-53C0-4DB2-8711-3323EDA2D541Q35215610-4F9A4866-BF82-4054-B7CE-0E429818D285Q35258162-DCC38CE2-87DA-4006-B143-DCD5851A1088Q35606675-A7C1AD9E-AC3A-4EFD-9246-A2C29F368776Q35658008-B4B8CFD8-A611-4446-B7F4-F8C39B7270BBQ35836354-F66B8F77-48F2-4764-9D20-34060E9BA4F0Q35840984-ACE7E2D2-6ED8-4D66-A0BA-658909B1ADCCQ35887012-F6C845A8-F6B2-4B25-BD21-F4E1F2315BA4Q35934788-C6E0A15D-80BE-4DAD-84FE-3255E3AEE677Q35961475-337786BA-6B1A-42DD-A3D1-B3748C096275Q36095262-92C9E09C-4BFC-4F57-9F26-FEBEF20881ABQ36108952-2079F41F-5597-4B59-9F91-43277CB82948Q36177134-8F4C99FC-B81C-42FF-8609-4A529040C445Q36177138-D296D69E-66AA-423C-B7BB-B34F951C1919Q36178032-29548D87-604F-4283-B05B-A0C2DDC9918EQ36195572-D0CC708E-AE5E-47B0-B134-C1FADA769BFB
P2860
The prevalence of hepatitis B virus infection in the United States in the era of vaccination.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The prevalence of hepatitis B ...... tes in the era of vaccination.
@en
The prevalence of hepatitis B ...... tes in the era of vaccination.
@nl
type
label
The prevalence of hepatitis B ...... tes in the era of vaccination.
@en
The prevalence of hepatitis B ...... tes in the era of vaccination.
@nl
prefLabel
The prevalence of hepatitis B ...... tes in the era of vaccination.
@en
The prevalence of hepatitis B ...... tes in the era of vaccination.
@nl
P2093
P356
P1476
The prevalence of hepatitis B ...... tes in the era of vaccination.
@en
P2093
Annemarie Wasley
Edgar P Simard
Geraldine McQuillan
Wendi Kuhnert
P304
P356
10.1086/653622
P407
P577
2010-07-01T00:00:00Z